delivery - International Biopharmaceutical Industry

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Volume 5 Issue 3

How to Keep Breathing – The Future of Inhaled Medication Testing

The delivery of therapeutics by inhalation is a medical process dating back thousands of years. The first written evidence of this can be found ca. 1550 BC in Egypt, ...

12 October 2022 Volume 5 Issue 3 bronchodilator | delivery

Continue Reading →

news

Halozyme, doubling down on a licensing strategy, buys a drug delivery biotech for nearly $1B

Dive Brief: Halozyme Therapeutics, a San Diego-based company whose business revolves around a type of drug delivery technology, announced Wednesday plans to expand...

14 April 2022 news delivery | Drug

Continue Reading →

news

How to eliminate design verification failure for your next device

If a drug delivery device fails a design verification test, the consequences can be far-reaching. If, for example, the volume of drug being delivered does not meet th...